Cargando…
Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes
BACKGROUND: Coronavirus disease-2019 (COVID-19) is a growing pandemic with an increasing death toll that has been linked to various comorbidities as well as racial disparity. However, the specific characteristics of these at-risk populations are still not known and approaches to lower mortality are...
Autores principales: | Crouse, Andrew B., Grimes, Tiffany, Li, Peng, Might, Matthew, Ovalle, Fernando, Shalev, Anath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838490/ https://www.ncbi.nlm.nih.gov/pubmed/33519709 http://dx.doi.org/10.3389/fendo.2020.600439 |
Ejemplares similares
-
Verapamil and beta cell function in adults with recent-onset type 1 diabetes
por: Ovalle, Fernando, et al.
Publicado: (2018) -
Reduced Mortality Associated With the Use of Metformin Among Patients With Autoimmune Diseases
por: Lin, Chun-Yu, et al.
Publicado: (2021) -
Why rare disease needs precision medicine—and precision medicine needs rare disease
por: Might, Matthew, et al.
Publicado: (2022) -
Editorial: Metformin: Beyond Diabetes
por: Bost, Frédéric, et al.
Publicado: (2019) -
GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin
por: Ouyang, Jing, et al.
Publicado: (2020)